Compare ELDN & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELDN | ZH |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.4M | 222.6M |
| IPO Year | 2014 | 2021 |
| Metric | ELDN | ZH |
|---|---|---|
| Price | $1.97 | $2.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $9.00 | $4.09 |
| AVG Volume (30 Days) | ★ 918.4K | 253.2K |
| Earning Date | 11-12-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $2.51 |
| 52 Week High | $4.49 | $4.52 |
| Indicator | ELDN | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 35.64 | 30.77 |
| Support Level | N/A | N/A |
| Resistance Level | $3.14 | $3.42 |
| Average True Range (ATR) | 0.27 | 0.20 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 3.83 | 3.33 |
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
Zhihu Inc is engaged in the operation of one online content community which monetizes through paid membership services, marketing services and other services in the People's Republic of China. It is an online content community where people come to find solutions, make decisions, seek inspiration, and have fun. Its community supports discussions ranging from everyday consumer decisions, such as purchasing products or planning travel, to more specialized areas on professional knowledge, technological developments including artificial intelligence and academic topics. It operates in single segment and its revenues are derived from within the PRC.